MACC1 and gastric cancer: From a molecular point of view, depressive symptom severity was significantly higher in gastric cancer patients having higher plasma levels of catecholamines, elevated metastasis-associated in colon cancer-1 (MACC1) oncogene levels and metastasis [52].